樂觀
$444.76
情境價格
$469.030
+1.735 (+0.37%)收盤時
HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.
HCA Healthcare Inc is a good buy right now, trading at $469.03, with a forward P/E of 13.85, indicating it is undervalued compared to its earnings potential. The recent analyst ratings show optimism, with BMO Capital giving an Outperform rating and a price target of $495, suggesting a potential upside of 5.55%. However, insider selling has increased by 1487.91%, which could be a concern for potential investors.
TD Cowen
$460
2026-10-12
TD Cowen
2026-10-12
目標價
$460
RBC Capital
$496
2026-10-07
RBC Capital
2026-10-07
目標價
$496
BMO Capital
$495
2026-09-22
BMO Capital
2026-09-22
目標價
$495
JPMorgan
$425
2026-08-20
JPMorgan
2026-08-20
目標價
$425
BofA
$425
2026-08-10
BofA
2026-08-10
目標價
$425
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Major Risks Loom for Stock Market Next Week Amid AI Trade Stumbles

HCA Healthcare Hosts National Prescription Drug Take Back Day

HCA Healthcare Announces Q3 2026 Earnings Call Details

HCA Healthcare Presents Annual Awards of Distinction

BMO Capital Initiates Coverage of HCA Healthcare with Outperform Rating
HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).
HCA Healthcare Inc is a good buy right now, trading at $469.03, with a forward P/E of 13.85, indicating it is undervalued compared to its earnings potential. The recent analyst ratings show optimism, with BMO Capital giving an Outperform rating and a price target of $495, suggesting a potential upside of 5.55%. However, insider selling has increased by 1487.91%, which could be a concern for potential investors.
22 analysts cover HCA: 16 rate it Buy, 6 Hold and 0 Sell. The average price target is 491.89.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。